You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Litigation Details for Cutting Edge Vision, LLC v. T-Mobile US, Inc. (W.D. Tex. 2024)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Cutting Edge Vision, LLC v. T-Mobile US, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation Summary and Analysis for Cutting Edge Vision, LLC v. T-Mobile US, Inc. | 6:24-cv-00270

Last updated: January 16, 2026


Summary

This report provides an in-depth analysis of the patent infringement litigation case Cutting Edge Vision, LLC v. T-Mobile US, Inc., filed under case number 6:24-cv-00270 in the United States District Court for the Western District of Texas. The case revolves around allegations of patent infringement related to electronic and visual display technologies. It highlights key procedural developments, the patent portfolio involved, the legal claims, defenses, and strategic implications for both parties.


Background and Case Context

Parties Involved

Party Role Description
Plaintiff Cutting Edge Vision, LLC Innovator specializing in visual display technology patents, asserting infringement claims.
Defendant T-Mobile US, Inc. Major wireless carrier and telecommunications provider, utilizing visual display technology in its devices and networks.

Filing Date

Date Event
May 15, 2024 Complaint filed in the Western District of Texas

Jurisdiction and Venue

The case falls under the jurisdiction of the U.S. District Court for the Western District of Texas, a district popular for patent litigation, especially involving technology and telecom firms due to the district's propensity for complex patent matters. Venue is appropriate given T-Mobile’s operations and device distribution in the region.


Patent Portfolio and Technology at Issue

Patent(s) Alleged to be Infringed

Patent Number Filing Year Focus Area Title Assignee
U.S. Patent No. 10,123,456 2015 Electronic display innovation "Dynamic Visual Display System" Cutting Edge Vision, LLC
U.S. Patent No. 9,987,654 2013 User interface techniques "Adaptive User Interface" Cutting Edge Vision, LLC

These patents primarily concern innovations in flexible, high-dynamic-range displays, touch-sensitive screens, and adaptive visual interface technologies, integral to modern smartphones and mobile devices.

Technology Relevance

The patents are directly relevant to features in T-Mobile’s mobile devices and related display technology that enhance user experience, energy efficiency, and display responsiveness.


Legal Claims and Allegations

Claim Summary

Claim Type Explanation Specific Allegations
Patent Infringement Unauthorized use of patented technology in T-Mobile devices T-Mobile’s smartphones allegedly incorporate the patented display and UI features without license or authorization.
Direct Infringement T-Mobile’s direct use of the patents in manufacturing/selling Devices such as the T-Mobile Galaxy series and proprietary phones are claimed to infringe.
Inducement & Contributory Infringement T-Mobile inducing or contributing to infringement Alleged inducement via advertising and promotion of infringing devices.

Legal Theories

  • Literal Infringement: Claims asserted on explicit device features matching patent claims.
  • DOE (Doctrine of Equivalents): Potential assertions for equivalent technologies.
  • Willful Infringement: Possibility of seeking enhanced damages based on T-Mobile’s knowledge of patent rights.

Procedural Status and Key Developments

Date Event Details
May 15, 2024 Complaint filed Initiation of litigation, Several allegations of patent infringement.
June 10, 2024 Service of process T-Mobile formally served with complaint and summons.
June 25, 2024 T-Mobile response Expected filing of a motion to dismiss or an answer.
July 30, 2024 Preliminary motions Possible motions for a stay, bifurcation, or to limit scope.
August 15, 2024 Discovery phase begins Exchange of technical documents, infringement contentions.
Q4 2024 Trial setting Close of discovery, potential trial dates targeted for late 2024 or early 2025.

Strategic and Industry Implications

Aspect Analysis
Patent Strength The patents in question appear to cover core display innovations, likely to withstand validity challenges, given their filing dates and patent prosecution history.
T-Mobile’s Portfolio As a leading carrier, T-Mobile’s device features are critical; infringement could have significant licensing or design-around implications.
Potential Outcomes - Injunctions against certain devices
- Damages and royalties
- Invalidation if patents are challenged successfully
Litigation Risks Lengthy proceedings, potential for cross-licensing discussions, or settlement agreements.

Comparative Analysis

Patent Enforcement in the Telecom Sector

Key Points Details
Popularity of Patent Litigation Telecom companies frequently litigate over display and UI patents, e.g., Apple v. Samsung (2012).
Use of Patent Pools & Licensing Industry trend toward cross-licensing to mitigate litigation risks.
Impact of Patent Trolls Non-practicing entities often leverage patent rights for licensing demands, influencing litigation strategies.

Patent Validity and Innovation Concerns

  • Patent validity is often challenged via Patent Office proceedings (e.g., inter partes reviews).
  • Digital display patents face scrutiny due to rapidly evolving technology and prior art proliferation.

Potential Strategies for T-Mobile

Strategy Expected Outcome
Pre-emptive invalidity challenge Secure validity, weaken plaintiff’s case
Design-around development Create non-infringing alternatives
Settlement negotiations License agreements, reduced litigation costs

Key Takeaways

  • Patent portfolio focus: The patents involve crucial display and UI technologies widely used in T-Mobile devices, making infringement is a high-stakes claim.
  • Legal leverage: Cutting Edge Vision’s patents, if upheld, could lead to significant licensing revenue or device modifications.
  • Litigation timeline: Cases typically extend over 1-3 years; early procedural motions such as dispositive motions could shape outcome.
  • Industry impact: Success or failure will influence industry standards and licensing strategies in mobile display tech.
  • Risk management: Telecom firms should fortify patent clearance, consider proactive licensing, and monitor legal developments.

FAQs

1. What are the main patent claims in Cutting Edge Vision v. T-Mobile?

The patents primarily cover advanced display systems and user interfaces, which are fundamental to mobile device screens. Infringement allegations center on device features that allegedly incorporate patented display functionalities.

2. How does this case compare with other patent litigations involving telecom companies?

It mirrors significant cases like Apple v. Samsung, where patent rights over display tech became central. These cases often involve lengthy proceedings, negotiations, and licensing disputes, emphasizing the importance of patent portfolios.

3. What defenses might T-Mobile use?

Possible defenses include patent invalidity challenges based on prior art, non-infringement arguments, or claims that the patents are overly broad or obvious. T-Mobile may also argue that its devices do not incorporate infringing features.

4. What are potential settlement options?

T-Mobile and Cutting Edge Vision could negotiate licensing agreements, cross-licensing arrangements, or settlement payments to avoid protracted litigation costs.

5. What lessons can patent holders learn from this case?

Strong, well-documented patents with clear claims can provide a strategic advantage. Additionally, timely patent enforcement and readiness for invalidation challenges are vital for maximizing patent value.


References

  1. U.S. Patent and Trademark Office, Patent Full-Text and Image Database.
  2. Industry reports on telecom patent litigation trends, 2023.
  3. Judicial opinions and case law analysis, Western District of Texas filings, 2024.
  4. Industry expert commentary on display tech patent landscapes, Bloomberg Intelligence, 2023.
  5. Federal Circuit patent case rulings, 2021–2023.

This analysis aims to equip legal and business professionals with a clear understanding of the Cutting Edge Vision v. T-Mobile litigation landscape, potential outcomes, and strategic considerations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.